Please ensure Javascript is enabled for purposes of website accessibility
Keith Speights

Keith Speights


Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles

Vaccine bottles

How Important Is Novavax's COVID Vaccine Manufacturing Deal With GlaxoSmithKline?

The small biotech is getting critical help from a big pharma company.

3 paper airplanes going up

Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?

One of the three clearly has the most upside potential.

Nasal spray

Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?

The short answer: It depends.

Dollar signs above a businessman's hands

Better Value Stock: AbbVie or Viatris?

Look at more than just the valuation metrics.

Vaccine vials - 2 knocked over and 2 standing

Why Moderna Stock Is Jumping Today

Bad news for its COVID-19 vaccine rivals could be good news for Moderna.

Breast cancer pink ribbon

Why Greenwich LifeSciences Stock Is Rising Today

The company reported positive data for its cancer immunotherapy candidate GP2.

DNA image over a hand

Could Illumina's Quest to Acquire GRAIL Fail?

The chances are certainly higher now that the deal won't happen.

3 cannabis leaves on a line chart

3 Best Marijuana Stocks so Far This Year: Are They Buys Now?

They have one notable thing in common.

Shopping cart with money

3 Robinhood Stocks That Are Ridiculously Cheap

You might be surprised by two of them.

Line going up with man on ladder

Could Humanigen Stock Soar Even Higher After Its COVID Antibody Results?

It's a definite maybe.

Young girl receiving vaccine

Why Didn't Pfizer and BioNTech Stocks Soar After Their COVID Vaccine Achieved 100% Efficacy in Kids?

There are several potential reasons why investors didn't cheer the companies' great news more loudly.

Dollar sign with question mark shadow

Robinhood Investors Are Buying Tonix Pharmaceuticals Stock. Should You?

There are two main reasons this small-cap biotech stock has gained a lot of attention.

Woman holding smartphone with dollar signs

3 Beaten-Down Cathie Wood Stocks to Buy Right Now

Their underlying businesses remain solid and their growth prospects are strong.

Cannabis leaf $100 bills

Why Cannabis Stocks Aphria, Aurora Cannabis, Charlotte's Web, and Tilray Slid Today

Investors appear to be jittery about the prospects for U.S. cannabis reform.

DNA helixes with doctor in background

Why Homology Medicines Stock Is Sinking Today

Dilution is on the way thanks to the company's latest stock offering.

Businessman looking down at red line descending

Why FibroGen Stock Is Crashing Today

The company disclosed a bombshell related to its safety results for lead candidate roxadustat.

Beaker with money

3 Top Biotech Stocks to Buy in April

These big biotechs check off all the boxes.

Infinity symbol formed by $100 bills

3 Robinhood Stocks You Can Buy and Hold Forever

Their businesses are built to survive and thrive over the long run.

Female scientist holding 2 test tubes

Why Cara Therapeutics Stock Is Soaring Higher Today

The biotech stock is being added to an important small-cap index.

People at conference table

How Does 10x Genomics Handle Product Development?

The genomics leader's process has evolved over time.